Protalix Biotherapeutics, Inc. (PLX)
2.32
+0.02
(+0.87%)
USD |
NYAM |
Apr 17, 16:00
2.315
0.00 (0.00%)
After-Hours: 20:00
Protalix Biotherapeutics SG&A Expense (Quarterly) : 3.526M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Agenus, Inc. | 12.30M |
| Lisata Therapeutics, Inc. | 2.045M |
| InspireMD, Inc. | 9.789M |
| Lifeward Ltd. | 5.363M |
| Denali Therapeutics, Inc. | 39.46M |